Document Detail

Effect of CCK pretreatment on the CCK sensitivity of rat polymodal gastric vagal afferent in vitro.
MedLine Citation:
PMID:  10950839     Owner:  NLM     Status:  MEDLINE    
To prevent the blood-borne interference and reflex actions via neighboring organs and the central nervous system, the study was conducted in an in vitro isolated stomach-gastric vagus nerve preparation obtained from overnight-fasted, urethan-anesthetized rats. Afferent unit action potentials were recorded from the gastric branch of the vagus nerve. The left gastric artery was catheterized for intra-arterial injection. In vitro we found that 1) 55/70 gastric vagal afferents (GVAs) were polymodal, responding to CCK-8 and mechanical stimuli, 13 were mechanoreceptive, and 2 were CCK-responsive; 2) sequential or randomized intra-arterial injections of CCK-8 (0.1-200 pmol) dose-dependently increased firing rate and reached the peak rate at 100 pmol; 3) the action was suppressed by CCK-A (Devazepide) but not by CCK-B (L-365,260) receptor antagonist; 4) neither antagonist blocked the mechanosensitivity of GVA fibers. These results are consistent with corresponding in vivo well-documented findings. Histological data indicate that the layered structure of the stomach wall was preserved in vitro for 6-8 h. Based on these results, it seems reasonable to use the in vitro preparation for conducting a study that is usually difficult to be performed in vivo. For instance, because there was no blood supply in vitro, the composition of the interstitial fluid, i.e., the ambient nerve terminals, can be better controlled and influenced by intra-arterial injection of a defined solution. Here we report that acutely changing the ambient CCK level by a conditioning stimulus (a preceding intra-arterial injection of increasing doses of CCK-8) reduced the CCK sensitivity of GVA terminals to a subsequent test stimulus (a constant dose of CCK-8 intra-arterial injection).
J Y Wei; Y H Wang
Related Documents :
19685009 - Combined intraarterial and intravenous thrombolysis for severe cerebral venous sinus th...
6732479 - Role of intra-arterial streptokinase in treatment of arterial thromboembolism.
1083329 - Massive gastrointestinal hemorrhage.
3245729 - Effects of the novel class ia and class iii antiarrhythmic agent rs-87337 on myocardial...
20494699 - Subselective intra-arterial chemotherapy infusion in the treatment of hepatocellular ca...
12382519 - Is intra-arterial chemotherapy useful in high-grade gliomas?
21429469 - Sphenopalatinum foramen: an anatomical study.
18627609 - Different outcome of six homozygotes for prothrombin a20210a gene variant.
19831489 - System and method for investigating arterial remodeling.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of physiology. Endocrinology and metabolism     Volume:  279     ISSN:  0193-1849     ISO Abbreviation:  Am. J. Physiol. Endocrinol. Metab.     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2000-09-19     Completed Date:  2000-09-19     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  100901226     Medline TA:  Am J Physiol Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  E695-706     Citation Subset:  IM; S    
Digestive Diseases Division, Department of Medicine, Center for Ulcer Research and Education/Digestive Diseases Research Center and Brain Research Institute, University of California Los Angeles School of Medicine, 90095, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Action Potentials / drug effects
Cholecystokinin / administration & dosage,  metabolism,  pharmacology*
Injections, Intra-Arterial
Mechanoreceptors / physiology
Neurons, Afferent / drug effects*
Physical Stimulation
Rats, Sprague-Dawley
Receptor, Cholecystokinin A
Receptor, Cholecystokinin B
Receptors, Cholecystokinin / antagonists & inhibitors
Stomach / anatomy & histology,  innervation
Vagus Nerve / cytology,  drug effects*
Grant Support
Reg. No./Substance:
0/Receptor, Cholecystokinin A; 0/Receptor, Cholecystokinin B; 0/Receptors, Cholecystokinin; 9011-97-6/Cholecystokinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Increased expression of GAD65 and GABA in pancreatic beta-cells impairs first-phase insulin secretio...
Next Document:  Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer pati...